<qa>  What is the name of the PHASE 1?A PHASE 1, RANDOMIZED, PLACEBO-CONTROLLED, MULTIPLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SHR0534 IN CHINESE TYPE 2 DIABETIC PATIENTS: 